Free tool
Medicare drug spending
Last checked: Nov 19, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations
Part D, 2024
$288.7B
Gross drug spending in the dataset
Part B, 2024
$60.8B
Gross drug spending in the dataset
Drugs listed
7
Part D and Part B
Total spending by year
- Part D
- Part B
View as table
| Year | Part D | Part B |
|---|---|---|
| 2020 | $194,092,038,339 | $37,778,829,680 |
| 2021 | $213,513,349,361 | $40,135,340,775 |
| 2022 | $239,779,215,689 | $44,241,259,745 |
| 2023 | $275,808,918,753 | $50,775,853,083 |
| 2024 | $288,667,842,058 | $60,838,164,403 |
Top 7 by total spending
2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.
| Drug | Part | Spending | Change | Beneficiaries | Per beneficiary | Per unit |
|---|---|---|---|---|---|---|
| Daptomycin Daptomycin | D | $121M | -9% | 35,354 | $3,413 | $50.13 |
| Cubicin* Daptomycin* · J0878 | B | $1.9M | -16% | 3,510 | $546 | $0.05 |
| Daptomycin (J0872) Daptomycin · J0872 | B | $1.0M | n/a | 475 | $2,210 | $0.22 |
| Daptomycin-0.9% NaCl Daptomycin In 0.9 % Sod Chlor | D | $232K | +546% | 334 | $695 | $0.81 |
| Daptomycin (J0877) Daptomycin · J0877 | B | $179K | +166992% | 412 | $434 | $0.06 |
| Daptomycin (J0873) Daptomycin · J0873 | B | $29K | n/a | 114 | $252 | $0.04 |
| Daptomycin-0.9% NaCl Daptomycin In 0.9 % Sod Chlor · J0874 | B | $703 | n/a | n/a | n/a | $0.07 |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.